Co-dydramol 10/500 - Pain
You are here : Home > Formulary Search > Co-dydramol 10/500 - Pain
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Fixed combinations are less preferred. RSCH - prescribe as separate components - combination is non-formulary at RSCH.
The MHRA advises when prescribing dihydrocodeine with paracetamol, the tablet strength and dose must be clearly indicated
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Co-dydramol 10/500
Indication :
Pain
Group Name :
Keywords :
Dihydrocodeine with paracetamol, non-opioid analgesia, analgesics, compound analgesics
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Co-dydramol 10/500 is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Pain .
- Alfentanil hydrochloride
- Aspirin
- Buprenorphine
- Cannabis (medicinal)
- Co-codamol
- Co-dydramol 20/500
- Co-dydramol 30/500
- Co-proxamol (Dextropropoxyphene hydrochloride/para
- Codeine phosphate
- Diamorphine hydrochloride
- Dihydrocodeine tartrate
- Fentanyl
- Gabapentin
- Ibuprofen
- Ketamine
- Meptazinol hydrochloride
- Methoxyflurane
- Morphine sulfate
- Nefopam hydrochloride
- Oxycodone
- Oxycodone with naloxone
- Paracetamol
- Pethidine hydrochloride
- Pregabalin
- Sufentanil
- Tramadol hydrochloride
- Tramadol with Dexketoprofen
- Tramadol with paracetamol
- Ziconotide acetate
Committee Recommendations (1)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.